Direct contribution of obesity to oxidative damage to macromolecules

Neuroendocrinology Letters

Volumn 33, Issue 4, 2012, Pages 453-461

  Karbownik Lewinska, Malgorzata ^a,b   Szosland, Janusz ^a   Kokoszko Bilska, Agnieszka ^a,b   Stepniak, Jan ^a   Zasada, Krzysztof ^a,b   Gesing, Adam ^a   Lewinski, Andrzej ^a,b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

8 oxo 7,8 dihydro 2 deoxyguanosine; Lipid peroxidation; Non communicable diseases; Obesity; Oxidative damage

Indexed keywords

4 HYDROXYALKENAL; 8 HYDROXYDEOXYGUANOSINE; C REACTIVE PROTEIN; CELL NUCLEUS DNA; FERRITIN; GLUCOSE; IRON; LIPID PEROXIDE; MALONALDEHYDE; MEMBRANE LIPID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; DIASTOLIC BLOOD PRESSURE; DNA DAMAGE; FEMALE; HUMAN; LIPID PEROXIDATION; MACROMOLECULE; MAJOR CLINICAL STUDY; MALE; OBESITY; PERIPHERAL LYMPHOCYTE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 84868378004     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Akamine EH, Marcai AC, Camporez JP, Hoshida MS, Caperuto LC, Bevilacqua E, et al (2010). Obesity induced by high-fat diet promotes insulin resistance in the ovary. J Endocrinol. 206: 65-74.
2. Ando K, Fujita T (2009). Metabolic syndrome and oxidative stress. Free Radic Biol Med. 47: 213-218.
3. de Assis AM, Rieger DK, Longoni A, Battu C, Raymundi S, da Rocha RF, et al (2009). High fat and highly thermolyzed fat diets promote insulin resistance and increase DNA damage in rats. Exp Biol Med. 234: 1296-1304.
4. Ausk KJ, Ioannou GN (2008). Is obesity associated with anemia of chronic disease? A population-based study. Obesity (Silver Spring). 16: 2356-2361.
5. Bianchini F, Kaaks R, Vainio H (2002). Overweight, obesity, and cancer risk. Lancet Oncol. 3: 565-574. (Pubitemid 34993644)
6. Cardona F, Túnez I, Tasset I, Montilla P, Collantes E, Tinahones FJ (2008). Fat overload aggravates oxidative stress in patients with the metabolic syndrome. Eur J Clin Invest. 38: 510-515. (Pubitemid 351832030)
7. Ceschi M, Gutzwiller F, Moch H, Eichholzer M, Probst-Hensch NM (2007). Epidemiology and pathophysiology of obesity as cause of cancer. Swiss Med Wkly. 137: 50-56. (Pubitemid 46225250)
8. Chrissobolis S, Miller AA, Drummond GR, Kemp-Harper BK, Sobey CG (2011). Oxidative stress and endothelial dysfunction in cerebrovascular disease. Front Biosci. 16: 1733-1745.
9. Cortes DF, Sha W, Hower V, Blekherman G, Laubenbacher R, Akman S, et al (2011). Differential gene expression in normal and transformed human mammary epithelial cells in response to oxidative stress. Free Radic Biol Med. 50: 1565-1574.
10. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A (2006). Biomarkers of oxidative damage in human disease. Clin Chem. 52: 601-623.
11. Demirbag R, Yilmaz R, Gur M, Celik H, Guzel S, Selek S, et al (2006). DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements. Int J Clin Pract. 60: 1187-1193. (Pubitemid 44363654)
12. Dobrian AD, Davies MJ, Schriver SD, Lauterio TJ, Prewitt RL (2001). Oxidative stress in a rat model of obesity-induced hypertension. Hypertension. 37(2 Part 2): 554-560. (Pubitemid 32199027)
13. Evans MD, Dizdaroglu M, Cooke MS (2004). Oxidative DNA damage and disease: induction, repair and significance. Mutat Res. 567: 1-61. (Pubitemid 39162992)
14. Flegal KM, Graubard BI, Williamson DF, Gail MH (2007). Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 298: 2028-2037. (Pubitemid 350074800)
15. Ford ES, Mokdad AH, Giles WH, Brown DW (2003). The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes. 52: 2346-2352. (Pubitemid 37059506)
16. Gosmanov AR, Smiley DD, Robalino G, Siquiera J, Khan B, Le NA, et al (2010). Effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects. Am J Physiol Endocrinol Metab. 299: E953-E958.
17. Harrison DG, Gongora MC (2009). Oxidative stress and hypertension. Med Clin North Am. 93: 621-635.
18. Kalisz M, Baranowska B, Bik W (2012). Do novel adipokines play a causative or only modulating role in the pathogenesis of obesity and metabolic disorders ? Neuroendocrinol Lett. 33: 11-15.
19. Karbownik M, Lewinski A (2003). Melatonin reduces Fenton reaction-induced lipid peroxidation in porcine thyroid tissue. J Cell Biochem. 90: 806-811. (Pubitemid 37392470)
20. Karbownik M, Lewinski A, Reiter RJ (2001). Anticarcinogenic actions of melatonin which involve antioxidative processes: comparison with other antioxidants. Int J Biochem Cell Biol. 33: 735-753. (Pubitemid 32524173)
21. Karbownik M, Reiter RJ (2000). Antioxidative effects of melatonin in protection against cellular damage caused by ionizing radiation. Proc Soc Exp Biol Med. 225: 9-22.
22. Karbownik-Lewinska M, Kokoszko A, Lewandowski K, Shalet SM, Lewinski A (2008). Growth hormone replacement reduces increased lipid peroxidation in growth hormone-deficient adults. Clin Endocrinol. 68: 957-964. (Pubitemid 351703954)
23. Karbownik-Lewinska M, Stepniak J, Krawczyk J, Zasada K, Szosland J, Gesing A, Lewinski A (2010). External hydrogen peroxide is not indispensable for experimental induction of lipid peroxidation via Fenton reaction in porcine ovary homogenates. Neuroendocrinol Lett. 31: 343-347.
24. Kokoszko A, Karbownik M, Lewinski A (2006). Increased lipid peroxidation in growth hormone-deficient adult patients. Neuroendocrinol Lett. 27: 225-230. (Pubitemid 43970798)
25. Kokoszko A, Dabrowski J, Lewinski A, Karbownik-Lewinska M (2010). Effects of growth hormone and insulin-like growth factor-I on the iron-induced lipid peroxidation in the rat liver and porcine thyroid homogenates. Neuroendocrinol Lett. 31: 517-523.
26. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydaqs N, Bosmans E (2009). Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis/chronic fatigue syndrome. Neuroendocrinol Lett. 30: 715-722.
27. Misra MK, Sarwat M, Bhakuni P, Tuteja R, Tuteja N (2009). Oxidative stress and ischemic myocardial syndromes. Med Sci Monit. 15: RA209-219.
28. Paz-Filho G, Lim EL, Wong ML, Licinio J (2011). Associations between adipokines and obesity-related cancer. Front Biosci. 16: 1634-1650.
29. Pelclova D, Navratil T, Fenclova Z, Vickova S, Kupka K, Urban P, et al (2011). Increased oxidative/nitrosative stress markers measured non-invasively in patients with high 2,3,7,8-tetrachlorodibenzo-p-dioxin plasma level. Neuroendocrinol Lett. 32 Suppl 1: 71-76.
30. Pischon T, Nöthlings U, Boeing H (2008). Obesity and cancer. Proc Nutr Soc. 67: 128-145. (Pubitemid 351543395)
31. Podborska M, Sevcikova A, Trna J, Dite P, Lojek A, Kubala L (2009). Increased markers of oxidative stress in plasma of patients with chronic pancreatitis. Neuroendocrinol Lett. 30 Suppl 1: 116-120.
32. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008). Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 371: 569-578. (Pubitemid 351232031)
33. Roberts CK, Barnard RJ, Sindhu RK, Jurczak M, Ehdaie A, Vaziri ND (2006). Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism. 55: 928-934. (Pubitemid 43902895)
34. Stasiak M, Zasada K, Lewinski A, Karbownik-Lewinska M (2010). Melatonin restores the basal level of lipid peroxidation in rat tissues exposed to potassium bromate in vitro. Neuroendocrinol Lett. 31: 363-369.
35. Szosland J, Kokoszko A, Zasada K, Stepniak J, Lewinski A, Karbownik-Lewinska M (2010). Obesity as a risk factor for oxidative damage to membrane lipids in postmenopausal women. Menopause Rev. 3: 159-164.
36. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006). Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 160: 1-40. (Pubitemid 43227479)
37. Vincent HK & Taylor AG (2006). Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes. 30: 400-418.
38. Yan RT, Yan AT, Anderson TJ, Buithieu J, Charbonneau F, Title L, et al (2009). The differential association between various anthropometric indices of obesity and subclinical atherosclerosis. Atherosclerosis. 207: 232-238.
39. Zeyda M, Stulnig TM (2009). Obesity, inflammation, and insulin resistance - a mini-review. Gerontology. 55: 379-386.